Stiles Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,314
Closed -$180K 194
2023
Q1
$180K Sell
10,314
-750
-7% -$10.7K 0.1% 174
2022
Q4
$102K Sell
11,064
-1,190
-10% -$11.1K 0.06% 173
2022
Q3
$106K Sell
12,254
-560
-4% -$5.56K 0.06% 163
2022
Q2
$104K Sell
12,814
-122
-0.9% -$1.17K 0.06% 170
2022
Q1
$157K Sell
12,936
-66
-0.5% -$1.39K 0.08% 182
2021
Q4
$444K Buy
+13,002
New +$509K 0.21% 110

Other funds holding NEO

Stiles Financial Services's NEO Position: Q2 2023 in Review

Stiles Financial Services sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 10,314 shares — an estimated $180K sold.

Stiles Financial Services first reported a position in NEO in Q4 2021 and held it in 6 quarters. The position peaked at $444K in Q4 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Stiles Financial Services reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Stiles Financial Services sold 10,314 NeoGenomics shares in Q2 2023, an estimated $180K.
  • Stiles Financial Services first reported a position in NeoGenomics in Q4 2021 and held it in 6 quarters.
  • Stiles Financial Services's NeoGenomics position peaked at $444K in Q4 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Stiles Financial Services's 13F filing for Q2 2023, filed 21 Jul 2023.